Elevated Plasma Aβ42 in Cognitively Impaired Individuals Taking ACE Inhibitor Antihypertensives.

about

Microglial Activation Is Modulated by Captopril: in Vitro and in Vivo Studies.

P2860

Q55204991-4A465F7E-840E-4008-A738-211E5DF68213

P2860

Elevated Plasma Aβ42 in Cognitively Impaired Individuals Taking ACE Inhibitor Antihypertensives.

Item

http://www.wikidata.org/entity/Q38690145

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Elevated Plasma Aβ42 in Cognit ...... E Inhibitor Antihypertensives.

@en

type

Item

label

Elevated Plasma Aβ42 in Cognit ...... E Inhibitor Antihypertensives.

@en

prefLabel

Elevated Plasma Aβ42 in Cognit ...... E Inhibitor Antihypertensives.

@en

P1476

Elevated Plasma Aβ42 in Cognit ...... E Inhibitor Antihypertensives.

@en

P2093

David J Loreck

http://www.w3.org/2001/XMLSchema#string

Gina Scarinzi

http://www.w3.org/2001/XMLSchema#string

Kristen L Mordecai

http://www.w3.org/2001/XMLSchema#string

Seshagiri R Doddi

http://www.w3.org/2001/XMLSchema#string

William T Regenold

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study

Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow.

Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.

Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression.

Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.

P304

347-352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1533317517707288

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lawrence W. Adler

Jacob Blumenthal

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28449585

http://www.w3.org/2001/XMLSchema#string

Elevated Plasma Aβ42 in Cognitively Impaired Individuals Taking ACE Inhibitor Antihypertensives.

about

P2860

P2860

Elevated Plasma Aβ42 in Cognitively Impaired Individuals Taking ACE Inhibitor Antihypertensives.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698